<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Polymerase chain reaction (PCR) was applied to detect the structural change accompanying the activation of oncogenes in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> and preleukemic states </plain></SENT>
<SENT sid="1" pm="."><plain>Point mutation of N-ras oncogene was examined by oligonucleotide differential hybridization coupled with PCR </plain></SENT>
<SENT sid="2" pm="."><plain>Five out of 17 AML patients were shown to have mutated N-ras gene </plain></SENT>
<SENT sid="3" pm="."><plain>These mutations could be used as a genetic marker to diagnose the residual malignant cells </plain></SENT>
<SENT sid="4" pm="."><plain>Philadelphia chromosome in <z:mp ids='MP_0005481'>CML</z:mp> was examined by cDNA synthesis and PCR with successful results </plain></SENT>
<SENT sid="5" pm="."><plain>PCR was shown to be a highly versatile and sensitive method which would be invaluable in clinical diagnosis </plain></SENT>
</text></document>